KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : Dok Hyun Yoon
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 13건 중 1-13 번을 표시중입니다.
1
Article
BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis
Jin Roh
;
Hyungwoo Cho
;
Hyo-Kyung Pak
;
et al
2022
2
Article
Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)
Kihyun Kim
;
Jin Seok Kim
;
Sung-Soo Yoon
;
et al
2022
3
Article
Clinical Outcomes and Effectiveness of Heart Transplantation in Patients With Systemic Light-chain Cardiac Amyloidosis
Hyehyun Jeong
;
Inhwan Hwang
;
Jwa Hoon Kim
;
et al
2022
4
Article
Comparison of clinical and laboratory characteristics of nonsecretory multiple myeloma and secretory multiple myeloma in a tertiary care hospital
Hee-Jeong Youk
;
Daehyun Chu
;
Chan-Jeoung Park
;
et al
2022
5
Article
Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma
Tan-Huy Chu
;
Sung-Hoon Jung
;
Kihyun Kim
;
et al
2022
6
Article
Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma
Meejeong Kim
;
Hee Sang Hwang
;
Dok Hyun Yoon
;
et al
2022
7
Article
Extra copy number of BCL2 is correlated with increased BCL-2 protein expression and poor survival in diffuse large B-cell lymphoma treated with chemoimmunotherapy
Hee Sang Hwang
;
Hyun-Jung Sung
;
Mee-Jeong Kim
;
et al
2022
8
Article
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study
Grzegorz S Nowakowski
;
Dok Hyun Yoon
;
Anthea Peters
;
et al
2022
9
Article
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features
Kwai Han Yoo
;
Dok Hyun Yoon
;
Hye Jin Kang
;
et al
2022
10
Article
Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)
Sung-Hoon Jung
;
Chang-Ki Min
;
Jae Hoon Lee
;
et al
2022
11
Article
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
Seong Hyun Jeong
;
Seok Jin Kim
;
Dok Hyun Yoon
;
et al
2022
12
Article
Significance of Single-cell Level Dual Expression of BCL2 and MYC Determined With Multiplex Immunohistochemistry in Diffuse Large B-Cell Lymphoma
Jin Roh
;
Dok Hyun Yoon
;
Yoon Kyoung Lee
;
et al
2022
13
Article
Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study
Lihua E Budde
;
Sarit Assouline
;
Laurie H Sehn
;
et al
2022
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide